Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) HNF4A Antibodies:
anti-Rat (Rattus) HNF4A Antibodies:
anti-Human HNF4A Antibodies:
Go to our pre-filtered search.
Human Polyclonal HNF4A Primary Antibody for ELISA, WB - ABIN4319471
Huang, Karakucuk, Levitsky, Rhoads: Expression of HNF4alpha variants in pancreatic islets and Ins-1 beta cells. in Diabetes/metabolism research and reviews 2008
Show all 4 Pubmed References
Cow (Bovine) Polyclonal HNF4A Primary Antibody for WB - ABIN2777514
Weedon, Owen, Shields, Hitman, Walker, McCarthy, Love-Gregory, Permutt, Hattersley, Frayling: Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. in Diabetes 2004
Show all 4 Pubmed References
Human Polyclonal HNF4A Primary Antibody for IHC, IHC (p) - ABIN4319472
Mezentsev, Amundson: Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model. in Radiation research 2011
Show all 2 Pubmed References
Human Polyclonal HNF4A Primary Antibody for PLA, WB - ABIN516575
Furumiya, Inoue, Ohta, Hayashi, Yuasa: Transcriptional regulation of PCFT by KLF4, HNF4?, CDX2 and C/EBP?: implication in its site-specific expression in the small intestine. in Biochemical and biophysical research communications 2013
Human Polyclonal HNF4A Primary Antibody for WB - ABIN4890036
Holmkvist, Almgren, Lyssenko, Lindgren, Eriksson, Isomaa, Tuomi, Nilsson, Groop: Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes. in Diabetes 2008
Human Polyclonal HNF4A Primary Antibody for IHC (p), WB - ABIN317780
Hu, Ma, Huang, Mao, Yang, Zhao, Li, Qiu, Yang, Zheng, Wang: Dihydrocapsaicin Attenuates Plaque Formation through a PPAR?/LXR? Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet. in PLoS ONE 2013
Here the authors report that loss of Drosophila HNF4 recapitulates hallmark symptoms of Maturity Onset Diabetes of the Young 1 (MODY1), including adult-onset hyperglycemia, glucose intolerance and impaired glucose-stimulated insulin (show INS Antibodies) secretion (GSIS).
Drosophila HNF4 mutants display diabetic phenotypes similar to those of sir2 (show SIRT1 Antibodies) mutants, and protein levels for dHNF4 are reduced in sir2 (show SIRT1 Antibodies) mutant animals. Sir2 (show SIRT1 Antibodies) exerts these effects by deacetylating and stabilizing dHNF4 through protein interactions.
Results support a feed-forward model for dHNF4, in which fatty acids released from triglycerides activate the receptor, inducing enzymes that drive fatty acid oxidation for energy production.
These results indicate a critical and conserved role for HNF4A in maintaining intestinal homeostasis in response to microbiota.
HNF4alpha is required for recruitment of the HDAC3 (show HDAC3 Antibodies)-PROX1 (show C16orf35 Antibodies) module in liver.
In summary, HNF4alpha isoforms perform non-redundant functions in the colon under conditions of stress, underscoring the importance of tracking them both in colitis and colon cancer.
Hnf4alpha silencing with shRNA transfection into auditory neuroblast cells (VOT-33) reduced cell viability
both iron-dextran injection and a 3% carbonyl iron-containing diet led to upregulation of hepatic inflammation, which was associated with a significant reduction in HNF4alpha expression and its downstream target, miR (show MLXIP Antibodies)-122.
Tg737 (show IFT88 Antibodies) regulates a Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies)/Snail (show SNAI1 Antibodies)-HNF4alpha negative feedback circuit, thereby blocking EMT (show ITK Antibodies) and the malignant transformation of liver stem cells to liver cancer stem cells.
Down regulation of HNF4 alpha plays a role in metabolic liver function and the pathogenesis of liver cancer.
A new organ culture system for adult murine oesophagus is described. Using this, Cdx2 (show CDX2 Antibodies) and HNF4alpha were ectopically expressed by adenoviral infection. We demonstrate the expression of CDX2 (show CDX2 Antibodies) and HNF4alpha in human biopsy samples.
Fibrotic levels of matrix stiffness significantly inhibit hepatocyte-specific functions in part by inhibiting the HNF4alpha transcriptional network mediated through the Rho/Rho-associated protein kinase pathway.
key role in controlling hepatic CES2 expression in diabetes, obesity, or nonalcoholic steatohepatitis
Although DNA methylation (show HELLS Antibodies) (5mC) and hydroxymethylation (5hmC) are highly dynamic during early embryonic development, less is known about their roles at later stages of differentiation. 5hmC marks HNF4A promoter 1 previous to terminal hepatocyte differentiation. TET1 (show TET1 Antibodies)-dependent 5hmC is required to activate promoter 1-driven HNF4A expression.
HNF4A alone could be a gold standard marker for distinguishing primary gastric cancer from breast metastasis
This work suggested that OA increased PKM1/PKM2 (show PKM2 Antibodies) ratio, resulting in HNF-4alpha activation and hepatoma differentiation.
this is the first report to clarify the expression pattern and function of HNF4alpha during the definitive endoderm differentiation.
HNF4A is central to the pathogenesis of NASH (show SAMSN1 Antibodies). This adds to previous literature demonstrating that HNF4A regulates the transcription of genes involved in the progression of NAFLD (show TSC2 Antibodies), and that HNF4A genetic variants play a potential role in NASH (show SAMSN1 Antibodies) progression
Specifically tested on two model systems, the power of iSPOT is demonstrated to accurately predict the structures of a large protein-protein complex (TGFbeta (show TGFB1 Antibodies)-FKBP12) and a multidomain nuclear receptor homodimer (HNF-4alpha), based on the structures of individual components of the complexes.
Apoptosis signal-regulating kinase 1 (ASK1 (show MAP3K5 Antibodies)) expression was dramatically suppressed and correlated with hepatocyte nuclear factor 4alpha (HNF4alpha) levels in hepatocellular carcinoma (HCC (show FAM126A Antibodies)) tissues.
2, 3-dihydroquinazolinone derivative, DHQZ-17, potently inhibited the expression of HNF4A, suppressing tumorigenicity of head and neck squamous cell carcinoma in vivo.
Examination of clinical samples revealed that HNF4alpha and IL-1R1 levels increase with increasing severity of Hp-induced gastritis and reach their highest levels in Gastric Carcinoma. Co-expression of HNF4alpha and IL-1R1 was a crucial indicator of malignant transformation from gastritis to GC.
HNF4 positively regulates pUPII gene promoter activity.
Tetra-primer ARMS-PCR identifies the novel genetic variations of bovine HNF-4alpha gene associating with growth traits.
Results show that chicken ovalbumin upstream promoter transcription factor (show NR2F1 Antibodies) II (COUP-TFII (show NR2F2 Antibodies)), hepatocyte nuclear factor 4alpha (HNF-4alpha) and HNF-4gamma regulate growth hormone receptor (show GHR Antibodies) 1A promoter activity through binding to a common DNA element
The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms.
hepatocyte nuclear factor 4 alpha
, hepatocyte nuclear factor 4, alpha
, hepatocyte nuclear factor 4-alpha-like
, hepatocyte nuclear factor 4-alpha
, hepatocyte nuclear factor 4
, hepatocyte nuclear factor 4 homologue
, HNF4 alpha
, Nuclear receptor 2A1
, nuclear receptor subfamily 2 group A member 1
, transcription factor 14
, transcription factor HNF-4
, alpha transcription factor 4
, hepatic nuclear factor 4, alpha
, hepatic nuclear factor 4 alpha
, hepatic nuclear factor 4
, hepatic nuclear factor 4alpha
, nuclear receptor